Ethics approval and consent to participate
The investigation was carried out in accordance with the latest version of the Declaration of Helsinki and approval for the study was obtained from the Ethical Committee of the Medical University of Vienna (EK 2013/2013) and the federal state of Lower Austria (GS4- EK-4/181/2012). Informed consent was obtained from all participants.
Consent for publication
Not applicable.
Availability of data and materials
The datasets supporting the conclusions of this article are available in the repository [https://mfr.osf.io/render?url=https%3A%2F%2Fosf.io%2Fqwmkj%2Fdownload].
Competing interests
The authors Ludwig, Carlberg, Kienesberger, Swoboda P, Swoboda M, Bernegger, Koller, Inaner, Senft, Meisner, Fuxjäger, Zotter, Fischer-Hansal, Schmelzle, Huber, Schoenthaler, Kapusta, Haslacher, Weinhaeusel, Aigner, and Schosser declare no competing interests. Siegfried Kasper received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, Celegne GmbH, Eli Lilly, Janssen-Cilag Pharma GmbH, KRKA-Pharma, Lundbeck A/S, Mundipharma, Neuraxpharm, Pfizer, Sanofi, Schwabe, Servier, Shire, Sumitomo Dainippon Pharma Co. Ltd. and Takeda.
Funding
This study was funded by a research grant (KLI°220) for “VieSAD” (“Vienna Study on Genetics of Suicidal Behavior in Affective Disorders”) from the Austrian Science Funds (FWF).
Authors' contributions
BL: Conception and design, acquisition of data, analysis and interpretation of data, manuscript writing, final approval of the version to be published
LC: Acquisition of data, analysis and interpretation of data, manuscript revision, final approval of the version to be published
KK: Acquisition of data, analysis and interpretation of data, manuscript writing, final approval of the version to be published
PS: Acquisition of data, manuscript revision, final approval of the version to be published
MS: Acquisition of data, manuscript revision, final approval of the version to be published
AB: Acquisition of data, manuscript revision, final approval of the version to be published
RK: Acquisition of data, manuscript revision, final approval of the version to be published
MI: Acquisition of data, manuscript revision, final approval of the version to be published
MF: Acquisition of data, manuscript revision, final approval of the version to be published
MZ: Acquisition of data, manuscript revision, final approval of the version to be published
NS: Acquisition of data, manuscript revision, final approval of the version to be published
BS: Acquisition of data, manuscript revision, final approval of the version to be published
LM: Acquisition of data, manuscript revision, final approval of the version to be published
DHF: Interpretation of data, manuscript revision, final approval of the version to be published
JH: Acquisition of data, manuscript revision, final approval of the version to be published
SS: Acquisition of data, manuscript revision, final approval of the version to be published
NDK: Conception and design, acquisition of data, analysis and interpretation of data, manuscript revision, final approval of the version to be published
HH: Analysis and interpretation of data, manuscript writing, final approval of the version to be published
MA: Conception and design, acquisition of data, analysis and interpretation of data, manuscript revision, final approval of the version to be published
AW: Analysis and interpretation of data, Acquisition of data, manuscript revision, final approval of the version to be published
SK: Conception and design, acquisition of data, analysis and interpretation of data, manuscript revision, final approval of the version to be published
AS: Principal investigator of the VieSAD study, conception and design, acquisition of data, analysis and interpretation of data, manuscript revision, final approval of the version to be published
All authors contributed to, read and approved the final manuscript.
Acknowledgements
Not applicable.